[ Price : $8.95]
FDA issues a safety communication on reprocessed duodenoscopes after interim study results show higher-than-expected contamination...[ Price : $8.95]
CDER deputy Center director for clinical science Bob Temple accepts a new position at the Center Office of New Drugs senior advis...[ Price : $8.95]
Federal Register notice: FDA seeks comments on a CDER/CBER framework for implementing a program to evaluate the potential use of r...[ Price : $8.95]
Federal Register proposed rule: FDA proposes to establish requirements for its medical device De Novo classification process.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Developing and Labeling In Vitro Companion Diagnostic Devic...[ Price : $8.95]
AbbVie stops enrollment in the TAHOE trial, a Phase 3 study evaluating rovalpituzumab tesirine as a second-line therapy for advanc...[ Price : $8.95]
CDER director Janet Woodcock selects Office of New Drugs deputy director Peter Stein as permanent director of the Office.[ Price : $8.95]
Indias Lupin Pharmaceuticals says FDA wrote up only "procedural" observations at three of its Mandideep generic drug manufacturing...